AB — AB Science SA Balance Sheet
0.000.00%
- €70.91m
- €85.05m
- €1.07m
Annual balance sheet for AB Science SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | — | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20.7 | 8.72 | 7.27 | 6.07 | 7.99 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.07 | 8.61 | 12.8 | 12.3 | 6.08 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26.3 | 18.2 | 20.9 | 19.4 | 14.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.82 | 1.59 | 1.27 | 0.785 | 0.899 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 29.7 | 21.3 | 23.8 | 25.5 | 23.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.6 | 17.5 | 23.1 | 18.7 | 20.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 49.2 | 44.5 | 59.5 | 46.5 | 46.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -19.5 | -23.2 | -35.7 | -21 | -23.8 |
| Total Liabilities & Shareholders' Equity | 29.7 | 21.3 | 23.8 | 25.5 | 23.2 |
| Total Common Shares Outstanding |